Review clinical trials related to Hemolytic Disease of Newborn. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
Risk Factors, and Clinical Outcomes of Neonatal Anemia in the NICU of a Tertiary Care Hospital
All live-born neonates admitted to the NICU within the first 24 hours of life. [+1]
Major congenital malformations [+2]
We hypothesized that adopting a lower rather than a higher threshold for phototherapy discontinuation will be associated with reduced rates of rebound hyperbilirubinemia in term and late preterm neonates with hemolytic disease of newborn. Objectives: The investigators aimed to compare the safety of implementing low-threshold, compared to high- threshold, of TSB for phototherapy interruption in term and late preterm neonates with hemolytic disease of newborn.
positive DAT and blood group iso-immunization (ABO / RH incompatibility);and /or [+1]
Major congenital abnormalities, [+3]